New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Inversago Pharma Raises $95 million CAD in Series C Financing
-
Form SC 13D Allakos Inc. Filed by: New Enterprise Associates 16, L.P.
-
G Squared and Transfix Mutually Agree to Terminate Business Combination Agreement
-
Topia Retains 'Strategic Leader' Status on Fosway 9-Grid™ for Third Straight Year
-
BIO Announces Appointment of Interim CEO
-
MBX Biosciences Advances Phase 1 Clinical Trial of Long-Acting Parathyroid Hormone Peptide Prodrug, MBX 2109
-
Leading Solo VC K2 Global Raises $300 Million to Invest in Start-ups Globally
-
AviadoBio Appoints Graeme Fielder as Chief Operating Officer and Alex Bloom as Chief Technical Officer
-
NEA Welcomes Philip Chopin as Partner
-
SpyGlass Pharma Presents Compelling 3-Month Data from the First-In-Human Trial of Its Innovative Drug Delivery Platform for Chronic Eye Conditions
-
Stride Health Continues Accelerated Growth with Appointment of Lee Hurley as Chief Marketing Officer
-
Cloudflare Announces $1.25 Billion “Workers Launchpad” Funding Program to Help Startups Grow Their Businesses
-
Lumos Pharma to Participate in the Cantor Neurology & Psychiatry Conference
-
Lumos Pharma to Participate in the Cantor Neurology & Psychiatry Conference
-
HEAVY.AI Launches Industry’s First Digital Twin for Telco Network Planning, Building and Operations, Leveraging the NVIDIA Omniverse Platform
-
APX Platform and Revelle Aesthetics, Inc. Enter Unique Strategic Partnership Focused on Growing Demand for Body Rejuvenation
-
Pionyr Immunotherapeutics Doses First Patient in Phase 1b Expansion Study of PY159
-
Allakos (ALLK) Prices 29.88M Share Offering at $5.02/sh
-
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock
-
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock
-
Lime Connect's Annual Ride to Rebrand Disability hosted in Reston, VA on October 8, 2022
-
SpyGlass Pharma to Unveil Innovative Drug Delivery Platform for Chronic Eye Conditions at Eyecelerator Prior to the American Academy of Ophthalmology Meeting
-
Lefteris Acquisition Corporation Announces Changes in Leadership
-
Arc Launches “Startup Growth Stories” Empowering Founders To Share Their Story
-
Amp X and Smartcar partner to bring smart charging to EV owners to lower energy bills, while making the grid more flexible
-
AVÉLI™ RECEIVES EXTENDED FDA CLEARANCE FOR THE LONG-TERM REDUCTION OF CELLULITE IN THE BUTTOCKS AND THIGHS
-
Lumos Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
-
Lumos Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
-
VIAVIA announces seed round of $8M to build the end-to-end solution for fashion e-commerce
-
Alnylam Pharma (ALNY) Appoints Elliott Sigal to its Board
-
Alnylam Announces Appointment of Elliott Sigal, M.D., Ph.D., to Board of Directors
-
Nitra Raises $62 Million to Revolutionize Fintech for the Healthcare Industry
-
AirSculpt® Technologies Launches Next Gen Cellulite Removal Technology, AirSculpt® Smooth
-
AirSculpt® Technologies Launches Next Gen Cellulite Removal Technology, AirSculpt® Smooth
-
Shima Capital Debuts with $200 Million to Support Web3 Founders through "Crypto Bear Market"
-
Moximed Raises $40 Million to Advance World’s First Implantable Shock Absorber for Knee Osteoarthritis
-
Lumos Pharma, Inc. (LUMO) Announces $3M Share Buyback
-
Lumos Pharma Announces Share Repurchase Program
-
Lumos Pharma Announces Share Repurchase Program
-
Wag! Announces Record Second Quarter 2022 Results, Exceeds Initial Revenue and Adjusted EBITDA Guidance
-
Wag! Announces Record Second Quarter 2022 Results, Exceeds Initial Revenue and Adjusted EBITDA Guidance
-
AI Gaming and Esports Startup Regression Games Raises $4.2M in Seed Funding from NEA and a16z
-
Form SC 13D ZeroFox Holdings, Inc. Filed by: New Enterprise Associates 14, L.P.
-
Celcuity Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
Jake R. Nunn Joins Board at Humanetics
-
Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
-
Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
-
Topia Acquires Pearl Global Tech, Bringing the Leading Immigration Risk Engine and Knowledge Base to its Global Talent Mobility Platform
-
Non-Alcoholic Retailer Boisson Closes $12M Seed Round to Expand Physical Footprint & Launch On-Premise Business
-
AviadoBio Appoints Dr. David Cooper as Chief Medical Officer

